Significant divestment in the medical laboratories sector

Together with VH Avocats, our firm assisted the management of a medical laboratory company who sold their shares to a larger market player for an undisclosed price of between 10 and 20 million euros. Some of the shares were also transferred to the buyer, as some of the sellers wished to continue supporting the company's growth. The structuring was based on the issue of preference shares to be held by active biologists, to enable them to maintain political control over the company, while having relinquished financial control, in accordance with the law.